Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
June 19, 2026
Applying Deep-Learning-Driven <i>De Novo</i> Design to Hit Identification: A Case Study on A<sub>2A</sub> Adenosine Receptor Antagonists
Margherita Persico, Alessandra Micoli, Veronica Salmaso, et al.
Journal of Medicinal Chemistry
|
March 24, 2010
The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition
Siew Lee Cheong, Anna Dolzhenko, Sonja Kachler, et al.
Bioorganic & Medicinal Chemistry
|
June 9, 2009
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites
Lisa Michielan, Chiara Bolcato, Stephanie Federico, et al.
Bioorganic & Medicinal Chemistry
|
March 23, 2010
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process
Giorgia Pastorin, Stephanie Federico, Silvia Paoletta, et al.
Journal of Chemical Information and Modeling
|
May 28, 2013
Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists
Magdalena Bacilieri, Antonella Ciancetta, Silvia Paoletta, et al.
Bioorganic Chemistry
|
July 26, 2024
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions
Ilenia Grieco, Davide Bassani, Letizia Trevisan, et al.
European Journal of Medicinal Chemistry
|
May 16, 2025
Acyclic purine and pyrimidine nucleotide analogs as ecto-5'-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Brehova, et al.
Journal of Medicinal Chemistry
|
January 11, 2011
Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility
Stephanie Federico, Silvia Paoletta, Siew Lee Cheong, et al.
Bioorganic & Medicinal Chemistry
|
September 13, 2011
Does the combination of optimal substitutions at the C²-, N⁵- and N⁸-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A₃ adenosine receptors?
Siew Lee Cheong, Anton V Dolzhenko, Silvia Paoletta, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta
Sara Calenda, Daniela Catarzi, Flavia Varano, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
June 19, 2026
Applying Deep-Learning-Driven <i>De Novo</i> Design to Hit Identification: A Case Study on A<sub>2A</sub> Adenosine Receptor Antagonists
Margherita Persico, Alessandra Micoli, Veronica Salmaso, et al.
Journal of Medicinal Chemistry
|
March 24, 2010
The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition
Siew Lee Cheong, Anna Dolzhenko, Sonja Kachler, et al.
Bioorganic & Medicinal Chemistry
|
June 9, 2009
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites
Lisa Michielan, Chiara Bolcato, Stephanie Federico, et al.
Bioorganic & Medicinal Chemistry
|
March 23, 2010
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process
Giorgia Pastorin, Stephanie Federico, Silvia Paoletta, et al.
Journal of Chemical Information and Modeling
|
May 28, 2013
Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists
Magdalena Bacilieri, Antonella Ciancetta, Silvia Paoletta, et al.
Bioorganic Chemistry
|
July 26, 2024
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions
Ilenia Grieco, Davide Bassani, Letizia Trevisan, et al.
European Journal of Medicinal Chemistry
|
May 16, 2025
Acyclic purine and pyrimidine nucleotide analogs as ecto-5'-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Brehova, et al.
Journal of Medicinal Chemistry
|
January 11, 2011
Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility
Stephanie Federico, Silvia Paoletta, Siew Lee Cheong, et al.
Bioorganic & Medicinal Chemistry
|
September 13, 2011
Does the combination of optimal substitutions at the C²-, N⁵- and N⁸-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A₃ adenosine receptors?
Siew Lee Cheong, Anton V Dolzhenko, Silvia Paoletta, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta
Sara Calenda, Daniela Catarzi, Flavia Varano, et al.
Page
of 6